Denmark· DK-28104565309

Lacidipin "Teva"

A lacidipine product containing lacidipin, registered in Denmark by Teva B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC C08CA09

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedLacidipin "Teva"ATCC08CA09REGISTER NO.DK-28104565309PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Lacidipine is registered in 7 of 19 countries.

Countries holding a registration under ATC C08CA09 (lacidipine), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 4 of them publish a price we can compare per daily dose

Lacidipine · ATC C08CA09

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Italyprice
  • Netherlands
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lacidipine costs, country by country.

Normalised to the WHO defined daily dose (4 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Lacidipine · price per daily dose (4 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.37
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
LACIDIPIN
Manufacturer
Teva B.V.
Country
Denmark (DK)
ATC code
C08CA09
ATC class
Lacidipine
Defined daily dose
4 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104565309

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for lacidipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lacidipine · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d3832ef5-5cba-4a5f-bb2c-56ebc535db3e
GET /v1/drugs/d3832ef5-5cba-4a5f-bb2c-56ebc535db3e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "4 mg",
  "auth_role": "CMS",
  "dk_drugid": "28104565309",
  "substance": "LACIDIPIN",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "40560"
}

See everything about lacidipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.